A dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2

Current Biology

Volumn 14, Issue 18, 2004, Pages 1621-1631

  Houghtaling, Benjamin R ^a   Cuttonaro, Leanora ^a   Chang, William ^a   Smith, Susan ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TINF2 PROTEIN, HUMAN; TINT1 PROTEIN, HUMAN;

ARTICLE; BIOLOGICAL MODEL; CELL CYCLE; COMPARATIVE STUDY; DNA SEQUENCE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HELA CELL; HUMAN; IMMUNOPRECIPITATION; METABOLISM; MOLECULAR GENETICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PLASMID; TELOMERE; TWO HYBRID SYSTEM;

BASE SEQUENCE; BLOTTING, NORTHERN; CELL CYCLE; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PLASMIDS; SEQUENCE ANALYSIS, DNA; TELOMERE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 4544258775     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.08.052     Document Type: Article

References (40)

1. Granger M.P., Wright W.E., Shay J.W. Telomerase in cancer and aging. Crit. Rev. Oncol. Hematol. 41:2002;29-40
2. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science. 297:2002;565-569
3. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:1985;405-413
4. Nugent C.I., Lundblad V. The telomerase reverse transcriptase. components and regulation Genes Dev. 12:1998;1073-1085
5. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460
6. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 346:1990;866-868
7. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015
8. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929
9. van Steensel B., de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature. 385:1997;740-743
10. Smorgorzewska A., de Lange T. Regulation of Telomerase by Telomeric Proteins. Annu. Rev. Biochem. 73:2004;177-208
11. Bilaud T., Brun C., Ancelin K., Koering C.E., Laroche T., Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat. Genet. 17:1997;236-239
12. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat. Genet. 17:1997;231-235
13. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P., de Lange T. A human telomeric protein. Science. 270:1995;1663-1667
14. Bianchi A., Smith S., Chong L., Elias P., de Lange T. TRF1 is a dimer and bends telomeric DNA. EMBO J. 16:1997;1785-1794
15. Ancelin K., Brunori M., Bauwens S., Koering C.E., Brun C., Ricoul M., Pommier J.P., Sabatier L., Gilson E. Targeting assay to study the cis functions of human telomeric proteins. evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2 Mol. Cell. Biol. 22:2002;3474-3487
16. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413
17. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325
18. Marcand S., Gilson E., Shore D. A protein-counting mechanism for telomere length regulation in yeast. Science. 275:1997;986-990
19. Smith S. The world according to PARP. Trends Biochem. Sci. 26:2001;174-179
20. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science. 282:1998;1484-1487
21. Smith S., de Lange T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10:2000;1299-1302
22. Cook B.D., Dynek J.N., Chang W., Shostak G., Smith S. Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol. Cell. Biol. 22:2002;332-342
23. Chang W., Dynek J.N., Smith S. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev. 17:2003;1328-1333
24. Kim S.H., Kaminker P., Campisi J. TIN2, a new regulator of telomere length in human cells. Nat. Genet. 23:1999;405-412
25. Ye J.Z., de Lange T. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nat. Genet. 36:2004;618-623
26. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 292:2001;1171-1175
27. Loayza D., Parsons H., Donigian J., Hoke K., de Lange T. DNA binding features of human POT1. a nonamer 5′-TAGGGTTAG-3′ minimal binding site, sequence specificity, and internal binding to multimeric sites J. Biol. Chem. 279:2004;13241-13248
28. Loayza D., de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 423:2003;1013-1018
29. Armbruster B.N., Linardic C.M., Veldman T., Bansal N.P., Downie D.L., Counter C.M. Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1. Mol. Cell. Biol. 24:2004;3552-3561
30. O'Connor, M.S., Safari, A., Liu, D., Qin, J., and Songyang, Z. (2004). The human Rap1 protein complex and modulation of telomere length. J. Biol. Chem.
31. Li B., Oestreich S., de Lange T. Identification of human Rap1. implications for telomere evolution Cell. 101:2000;471-483
32. Li B., de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol. Biol. Cell. 14:2003;5060-5068
33. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 295:2002;2446-2449
34. Liu D., Safari A., O'Connor M.S., Chan D.W., Laegeler A., Qin J., Songyang Z. PTOP interacts with POT1 and regulates its localization to telomeres. Nat. Cell Biol. 6:2004;673-680
35. Ye J.Z., Hockemeyer D., Krutchinsky A.N., Loayza D., Hooper S.M., Chait B.T., de Lange T. POT1-interacting protein PIP1. a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex Genes Dev. 18:2004;1649-1654
36. Bartel P.L., Chien C., Sternglanz R., Fields S. Using the two-hybrid system to detect protein-protein interaction. Harley D.A. Cellular interactions in development. a practical approach:1993;153-179 IRL Press, Oxford
37. Hollenberg S.M., Sternglanz R., Cheng P.F., Weintraub H. Identification fo a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 15:1995;3813-3822
38. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602
39. de Lange T., Shiue L., Myers R.M., Cox D.R., Naylor S.L., Killery A.M., Varmus H.E. Structure and variability of human chromosome ends. Mol. Cell. Biol. 10:1990;518-527
40. Dynek J.N., Smith S. Resolution of sister telomere association is required for progression through mitosis. Science. 304:2004;97-100